162 related articles for article (PubMed ID: 12675269)
1. Interleukin-2 activated NK cells do not use the CD95L- and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cells.
Velthuis JH; de Bont HJ; Medema JP; Kuppen PJ; Mulder GJ; Nagelkerke JF
Immunobiology; 2003; 207(2):115-27. PubMed ID: 12675269
[TBL] [Abstract][Full Text] [Related]
2. Impaired activation of caspases and prevention of mitochondrial dysfunction in the metastatic colon carcinoma CC531s-m2 cell line.
Velthuis JH; Gavric Z; de Bont HJ; Nagelkerke JF
Biochem Pharmacol; 2005 Feb; 69(3):463-71. PubMed ID: 15652237
[TBL] [Abstract][Full Text] [Related]
3. Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis.
Velthuis JH; Rouschop KM; De Bont HJ; Mulder GJ; Nagelkerke JF
J Biol Chem; 2002 Jul; 277(27):24631-7. PubMed ID: 11980895
[TBL] [Abstract][Full Text] [Related]
4. Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway.
Vermijlen D; Luo D; Robaye B; Seynaeve C; Baekeland M; Wisse E
Hepatology; 1999 Jan; 29(1):51-6. PubMed ID: 9862849
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells.
Mariani SM; Matiba B; Armandola EA; Krammer PH
J Cell Biol; 1997 Apr; 137(1):221-9. PubMed ID: 9105050
[TBL] [Abstract][Full Text] [Related]
6. Perforin and granzyme B induce apoptosis in FasL-resistant colon carcinoma cells.
Vermijlen D; Froelich CJ; Luo D; Suarez-Huerta N; Robaye B; Wisse E
Cancer Immunol Immunother; 2001 Jun; 50(4):212-7. PubMed ID: 11459173
[TBL] [Abstract][Full Text] [Related]
7. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression.
Matter-Reissmann UB; Forte P; Schneider MK; Filgueira L; Groscurth P; Seebach JD
Xenotransplantation; 2002 Sep; 9(5):325-37. PubMed ID: 12199864
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage.
Mariani SM; Krammer PH
Eur J Immunol; 1998 Mar; 28(3):973-82. PubMed ID: 9541592
[TBL] [Abstract][Full Text] [Related]
9. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
[TBL] [Abstract][Full Text] [Related]
11. TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria.
Thomas WD; Zhang XD; Franco AV; Nguyen T; Hersey P
J Immunol; 2000 Nov; 165(10):5612-20. PubMed ID: 11067917
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
13. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
15. CD95-mediated apoptosis of human glioma cells: modulation by epidermal growth factor receptor activity.
Steinbach JP; Supra P; Huang HJ; Cavenee WK; Weller M
Brain Pathol; 2002 Jan; 12(1):12-20. PubMed ID: 11770895
[TBL] [Abstract][Full Text] [Related]
16. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.
Tillman DM; Izeradjene K; Szucs KS; Douglas L; Houghton JA
Cancer Res; 2003 Aug; 63(16):5118-25. PubMed ID: 12941843
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
Lamothe B; Aggarwal BB
J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810
[TBL] [Abstract][Full Text] [Related]
19. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
